US5118613A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Determination of hdl whole blood
Assignee: Abbott Laboratories
•
Filing: 1989-11-17
•
Granted: 1992-06-02
•
Expires: 2009-11-17
Abstract
Abstract A method for separating HDL from whole blood anticoagulated with EDTA is disclosed. The method includes, as a first step, mixing the anticoagulated whole blood with an aqueous solution composed of magnesium ++ cations and dextran sulfate 500 in such proportions and of such concentration (a) that substantially all of the LDL and VLDL lipoproteins and substantially all of the chylomicrons are precipitated while (b) substantially all of the HDL remains in solution. The method also includes the step of sedimenting the precipitated lipoproteins, the chylomicrons and the red blood cells by centrifuging, which can be low gravity centrifuging, and can include the step of determining the cholesterol, triglyceride, phospholipid or protein content of the supernatant. Also disclosed is a method wherein the reagent additionally contains a colored species which can be used to determine dilution of the supernatant, and which includes the additional steps of determining the dilution of the supernatant and the dilution factor, and multiplying the value determined for cholesterol, triglyceride, phospholipid or protein content of the supernatant times the dilution factor to determine the corresponding content of the blood sample.
Inventors
- 👤 Michael W. McGowan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 14:55
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/92; C; C12; C12Q; C12Q1/00; C12Q1/60; G01N2800/00; G01N2800/04; G01N2800/044; Y; Y10; Y10T; Y10T436/00; Y10T436/25; Y10T436/25375; Y10T436/25625
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
158 words
A method for determining HDL cholesterol in whole blood anticoagulated with EDTA which comprises mixing the whole blood with an aqueous pretreatment reagent comprising magnesium ++ cations, dextran sulfate and an iron ++ complex with 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p'-disulfonic acid, sedimenting the resultant precipitated lipoproteins, chylomicrons and the red blood cells by centrifugation at not more than about 1000×gravity for about 2 minutes, combining the resultant supernatant with a HDL cholesterol determination reagent and determining the dilution and the dilution factor of the supernatant, determining the quantitative value of the HDL cholesterol content of the supernatant and multiplying the determined quantitative value times the dilution factor to determine the HDL cholesterol content of the whole blood sample, wherein the magnesium ++ cations and dextran sulfate are present in such proportions and of such concentration that substantially all of the LDL and VLDL lipoproteins and substantially all of the chylomicrons are precipitated while substantially all of the HDL cholesterol remains in solution.
Claim 2
Independent Claim
158 words
A method for determining HDL cholesterol in whole blood anticoagulated with EDTA which comprises mixing the whole blood with an aqueous pretreatment reagent comprising magnesium ++ cations, dextran sulfate and an iron ++ complex with 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p'-disulfonic acid, sedimenting the resultant precipitated lipoproteins, chylomicrons and the red blood cells by centrifugation at not more than about 1000×gravity for about 2 minutes, combining the resultant supernatant with a HDL cholesterol determination reagent and determining the dilution and the dilution factor of the supernatant, determining the quantitative value of the HDL cholesterol content of the supernatant and multiplying the determined quantitative value times the dilution factor to determine the HDL cholesterol content of the whole blood sample, wherein the magnesium ++ cations and dextran sulfate are present in such proportions and of such concentration that substantially all of the LDL and VLDL lipoproteins and substantially all of the chylomicrons are precipitated while substantially all of the HDL cholesterol remains in solution.
Claim 3
Dependent Claim
25 words
A method as claimed in claim 1 wherein substantially one volume of the blood sample is mixed with one volume of the aqueous pretreatment reagent.
Claim 4
Dependent Claim
19 words
A method as claimed in claim 1 wherein the centrifugation is conducted at from about 500×gravity to about 1000×gravity.
Claim 5
Independent Claim
168 words
A method for determining HDL cholesterol, triglycerides, phospholipids or protein content of a whole blood sample anticoagulated with EDTA which comprises mixing the whole blood sample with an aqueous pretreatment comprising an iron ++ complex with 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p'-disulfonic acid and magnesium ++ cations and dextran sulfate in such proportions and of such concentration that substantially all of the LDL and VLDL lipoproteins and chylomicrons are precipitated while substantially all of the HDL cholesterol remains in solution, centrifuging said sample and pretreatment reagent for at least about 2 minutes at from about 500×gravity to about 1000×gravity, combining the resultant supernatant with a determination reagent selected from the group consisting of HDL cholesterol, triglyceride, phospholipid and protein determining reagents and determining the dilution and dilution factor of the supernatant mixture, determining the quantitative value of the HDL cholesterol, triglyceride, phospholipid, or protein content of the supernatant mixture and multiplying the quantitative value times the dilution factor to determine the HDL cholesterol, triglyceride, phospholipid or protein content of the whole blood sample.
Claim 6
Independent Claim
168 words
A method for determining HDL cholesterol, triglycerides, phospholipids or protein content of a whole blood sample anticoagulated with EDTA which comprises mixing the whole blood sample with an aqueous pretreatment comprising an iron ++ complex with 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p'-disulfonic acid and magnesium ++ cations and dextran sulfate in such proportions and of such concentration that substantially all of the LDL and VLDL lipoproteins and chylomicrons are precipitated while substantially all of the HDL cholesterol remains in solution, centrifuging said sample and pretreatment reagent for at least about 2 minutes at from about 500×gravity to about 1000×gravity, combining the resultant supernatant with a determination reagent selected from the group consisting of HDL cholesterol, triglyceride, phospholipid and protein determining reagents and determining the dilution and dilution factor of the supernatant mixture, determining the quantitative value of the HDL cholesterol, triglyceride, phospholipid, or protein content of the supernatant mixture and multiplying the quantitative value times the dilution factor to determine the HDL cholesterol, triglyceride, phospholipid or protein content of the whole blood sample.
Claim 7
Dependent Claim
18 words
A method as claimed in claim 4 wherein the dilution and dilution factor are determined by absorption spectrophotometry.
References Cited (Backward Citations)
US4699887A
Cited
US4772561A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-06-02 | 1995-12-02 | 1996-06-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-06-02 | 1999-12-02 | 2000-06-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-06-02 | 2003-12-02 | 2004-06-02 | $7700.00 | Window Closed / Lapsed |